U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07676370) titled 'PROV-MESH: Prophylactic Ovarian Cancer MESH' on June 24.
Brief Summary: Incisional hernia is a common complication after midline laparotomy and may significantly impact quality of life, morbidity, and healthcare costs. Patients undergoing cytoreductive surgery for ovarian cancer are considered at increased risk due to extensive surgical procedures, nutritional status, and exposure to systemic treatments.
This prospective randomized clinical trial aims to evaluate whether prophylactic mesh placement during abdominal wall closure reduces the incidence of incisional hernia compared with conventional fascial closure in women undergoing ...